Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project.

David W. Dodick, Richard B. Lipton, Michel D. Ferrari, Peter J. Goadsby, Douglas McCrory, F. Michael Cutrer, Paul Williams

Research output: Contribution to journalReview article

13 Scopus citations


Seven oral triptans, which differ on a range of attributes important for treatment selection, are now available for treating migraine. US neurologists were surveyed to assess the relative importance of treatment attributes, prespecified by clinical relevance and availability of controlled study data, for selecting among oral triptans. Using a multiattribute decision model, we combined these data on the importance of treatment attributes with information on the relative performance of the oral triptans derived from a recent meta-analysis of controlled clinical trials.

Original languageEnglish (US)
Pages (from-to)435-442
Number of pages8
JournalCurrent pain and headache reports
Issue number6
StatePublished - Dec 2004
Externally publishedYes


ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this